Clinicians Answer Additional Medical Questions From LuMind IDSC Research Rally Panel Q&A
The 2019 Research Rally Breakfast at the NDSC Annual Convention was attended by 400 families of loved ones with DS with over 200 questions for the Research and Medical Care […]
LIFE-DSR Study – Why Natural History Studies Are Important on the Path to New Treatments
In the next couple of months, LuMind IDSC will launch the LIFE-DSR (Longitudinal Investigation for Enhancing Down Syndrome Research) study. This is a first for LuMind IDSC and represents an […]
Cerveau Technologies, Inc. Announces Partnership with LuMind IDSC to Expand LIFE DSR Study
The LuMind IDSC Foundation is excited to welcome a new Research Partner to the community! BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration with the LuMind IDSC Foundation (LuMind […]
LuMind Research Down Syndrome Foundation Launches the Down Syndrome Clinical Trials Network
BURLINGTON, Mass. [November 1], 2018 – With a combined $3M commitment from the Alana Foundation and biopharmaceutical companies H. Lundbeck A/S and AC Immune SA, the LuMind Research Down Syndrome […]
Published results on the Roche Clinical Trials for CLEMATIS expected in the first half of 2019
Many of you have asked LuMind RDS about the publishing of the results of the Hoffman-La Roche (Roche) trials that took place from 2011 to 2016 with their GABA-A targeting molecule basmisanil […]
New Trans-NIH INCLUDE Project for Down Syndrome will provide up to $261M Over 5 Years
MARLBOROUGH, MA. (June 22, 2018) — On Friday, June 21, The National Institute of Health (NIH) unveiled the details of the new trans-NIH initiative devoted to individuals with Down syndrome: the […]
Historic ~65% increase for NIH Down syndrome research
Marlborough MA, May 27, 2017 — On Thursday this week, Congress’ House Labor and Health and Human Services Appropriations Subcommittee Chairman Tom Cole (R-OK) announced a historic and major increase […]
Increased Commitment to Down Syndrome Research Included in 2018 Omnibus Spending Bill
New trans-NIH Down Syndrome Initiative aims for scientific discoveries to improve the health and neurodevelopment of individuals with Down syndrome LuMind™ Research Down Syndrome Foundation (LuMind RDS) joins other Down […]